Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism BRD4 inhibitors(Bromodomain-containing protein 4 inhibitors), EP300 inhibitors(Histone acetyltransferase p300 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H28N6O3S |
InChIKeyLMLIBNUOIWAJFC-UHFFFAOYSA-N |
CAS Registry2344825-52-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | US | 25 Jan 2022 |